Literature DB >> 31528306

Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stage.

Fereshteh Pashayee-Khamene1, Mahdi Saber-Firoozi2, Behzad Hatami3, Bahram Rashidkhani4, Vahideh Aghamohammadi5, Elahe Mohammadi6, Azita Hekmatdoost1.   

Abstract

AIM: The aim of this study was to determine the relation between different food groups intake, nutritional status of cirrhotic patient and the stage of the disease.
BACKGROUND: Protein-energy malnutrition (PEM) is a common problem in cirrhotic patients. Food intake assessment is highly important in the investigation regarding the health-disease process.
METHODS: In this cross-sectional study, sixty eight ambulatory cirrhotic patients, with a mean age of 54 years, were included. In order to assess the stage of the disease and malnutrition status, Child-Pugh score and Subjective Global Assessment index were used respectively. Dietary intakes were assessed using a 168-item semi-quantitative validated food frequency questionnaire. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were computed, using logistic regression models.
RESULTS: After adjustment for confounders, we found significant inverse relations between intakes of nuts (OR=0.140, CI=0.031-0.625) and olive (OR=0.212, CI=0.049-0.917) with severity of disease and boiled potatoes (OR=0.154, CI=0.040-0.592) and legumes (OR=0.090, CI=0.020-0.406) with malnutrition status. Inversely, solid fats (OR=3.324, CI=1.080-10.238) and mayonnaise (OR=5.215, CI=1.203-22.612) were positively associated with disease severity and malnutrition, respectively.
CONCLUSION: These findings suggest that selection of healthy foods was negatively associated with severity of hepatic cirrhosis whereas unhealthy food groups had a positive relation with disease severity and malnutrition.

Entities:  

Keywords:  Child-Pugh score; food groups; hepatic cirrhosis; malnutrition

Year:  2019        PMID: 31528306      PMCID: PMC6668758     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


Introduction

Protein energy malnutrition (PEM) is highly prevalent in cirrhotic patients and differs from 60-100% in decompensated to 20-30% in compensated patients and even reaches to 75% in ambulatory patients (1). Patients with severe disease (Child-Pugh’s grading of B and C) usually suffer from severe malnutrition (1). PEM would adversely affect the general and clinical status, liver function, morbidity and mortality in cirrhotic patients as well as reduced survival when such patients undergo liver transplantation (2, 3). Several factors contribute to malnutrition including poor oral intake, malabsorption, metabolic abnormality, increased energy requirement and disturbances in substrate utilization such as reduced glucose oxidation and increased lipid oxidation, accelerated protein breakdown and inefficient patient’s synthesis (4). Assessment of dietary intake is crucial for monitoring the disease course in cirrhotic patients. There are several methods to evaluate the quality and quantity of nutrient intake in liver disease patients; however, Subjective Global Assessment (SGA) is considered an optimal method because it does not include the parameters of nutritional status or biochemical values which might be affected by liver dysfunction (2, 5). It has been shown that the progression of malnutrition is associated with disease severity (6). Generally accepted methods for assessing the clinical status and severity of disease in cirrhotic patients are the Child-Pugh-Turcotte classification (5, 7). Although some studies have shown the high prevalence of malnutrition in cirrhotic patients and its relation with disease prognosis, there is no study evaluating the role of various food items in disease progression and malnutrition. Therefore, assessing dietary behavior of cirrhotic patients appears essential to increase the knowledge in this domain and to identify the role of nutritional factors in disease progression. The present cross-sectional study aimed to evaluate the association between dietary food groups, nutritional status of the patient and the stage of the disease among Iranian populations.

Methods

Subjects In this cross-sectional study, sixty eight ambulatory cirrhotic patients (with more than 6 months of cirrhosis diagnosis), with a mean age of 54 years, were recruited from two educational hospitals of Tehran (capital of Iran) from September 2016 to February 2017. Majority of patients (67.7%) had hepatitis C viral etiology and were male (72%). All patients gave written informed consent before inclusion (participation rate >97%). Exclusion criteria were the following: pregnancy, chronic renal or cardiac diseases, diabetes mellitus, pancreatic insufficiency, neoplasia and acquired immuno deficiency syndrome. The diagnosis of cirrhosis was based on the medical history, physical examination, biochemical findings and imagistic methods (ultrasound and /or computed tomography). Study protocol was approved by the Ethical Committee for Research at Shahid Beheshti University of Medical Sciences with ethical code Ir.sbmu.nnftri.1396.186. Dietary assessment We evaluated dietary intake of patients using a validated Food Frequency questionnaire (FFQ) (8). The questionnaire included 168 food and beverage items, categorized in 13 food groups (vegetables, fruits, dairy, grains, animal source proteins, liquid oil, sweets, boiled potato, nuts, solid fats, legumes, mayonnaise, and olive). Subjects were asked to specify their frequency of consumption for each food item on a daily, weekly, monthly or yearly basis. Intakes were then converted to daily frequencies and a manual for household measures was used to convert intake frequencies to grams of food intake/day. For each group portion size was estimated using either usual containers (for example spoon or standard unit as yogurt) or a set of validated color photographs. Nutritional assessment Nutritional assessment was accomplished by using SGA according to the proposition of Destky et al. (9). The standard SGA includes nutritional evaluation of height, weight (current, before illness and weight variation in the previous 6 months), nutritional history (appetite, intake, and gastrointestinal symptoms), physical examination assessment of fat loss, muscle wasting, and presence of ascites or encephalopathy, infections and renal insufficiency. Body weight was measured in lightweight clothing and without shoes to the nearest 0.5 kg, using a scale (Seca, Germany). Height was measured by a mounted tape without shoes to the nearest 0.1 cm accuracy using a stadiometer (Seca, Germany). Body mass index (BMI) was calculated as the weight in kilogram divided by the square of the height in meters. Based on this evaluation, patients were classified prospectively into three groups: A: well-nourished B: moderately malnourished C: severely malnourished. The severity of liver disease was assessed by the child-pugh classification. The score was calculated by serum albumin, total bilirubin, international normalized ratio (INR), and presence of ascites or encephalopathy. Covariates Data about lifestyle (educational level, socioeconomic status, marital status, smoking status, and physical activity level), nutritional behaviors (alcohol consumption and food supplements) and medical history (such as high blood pressure, diabetes) and current treatment were collected at inclusion using questionnaires. Anthropometric indices were measured accurately (10). Statistical analysis We performed statistical analyzes of the data by using SPSS (Statistical Package for the Social Science) version.22. A p value of <0.05 was taken as significant. Due to the low number of patients in C class of child-pugh and SGA, they were stratified into two groups (conversion of 3-state to 2-state). The quantitative variables were expressed as mean and standard deviation, and qualitative variables were shown by absolute and relative frequencies. To compare means in two groups, the Student t test was used. The chi-square test of Pearson was applied for categorical variables. We used logistic regression models to examine the association between different food group consumption, severity of malnutrition and stage of the disease. Logistic regression was adjusted for age and energy in model 1; and age, energy, BMI, smoking and alcohol consumption in model 2. Characteristics of participants (n=68) according to Child-pugh score BMI: body mass index; T-test or Mann-Whitney U test were used for comparison of quantitative variables and chi-square test or Fisher’s exact test were used for comparison of qualitative variables; p value< 0.05 Association of food groups intake (according to median) with Child-Pugh score p<0.05; Low and high is according to median; Fisher exact test or chi-square test; n (%) = Number and percent of patients Association of different food groups intake (according to median) with severity of malnutrition Odds ratio (OR) and 95% (CI) of malnutrition and severity of disease by food groups intake according to adjusted model p<0.05; Model 1: adjusted for energy and age; Model 2: model 1 plus BMI, smoking and alcohol consumption

Results

Table 1 shows the demographic characterization according to the severity of cirrhosis. This study included 68 adult cirrhotic patients with a mean age of 54.63years. Patients were mainly men (72.1%) and the most prevalent etiology of hepatic cirrhosis was hepatitis C virus (67.7%). As for the severity of the disease, the majority of patients, 47 (69.1%), were Child-Pugh A, while 21 (30.9%) were Child-Pugh B and only one patient was assigned to Child-Pugh C. Child-Pugh A patients were significantly different from Child-Pugh B and C patients in the case of weight and height (p≤0.05).
Table 1

Characteristics of participants (n=68) according to Child-pugh score

Characteristics Total participants (n =68) Child-pugh
A (n=47) B and C(n=21)
Mean±SD Mean±SD Mean±SD
Age 54.63±11.6754.70±11.8154.47±11.64
Weight 73.69±15.1076.36±16.1968.59±10.38b
Height 167.38±7.78169.14±7.54163.42±6.96b
BMI26.68±4.9927.00±5.5025.95±3.63
n (%) n (%) n (%)
Etiology
Virus44(67.7)32(72.7)12(27.3)
other21(32.3)14(66.7)7(33.3)
Sex
Male49(72.1)34(69.4)15(30.6)
female19(27.9)13(68.4)6(31.6)
Obesity
Yes21(30.9)17(81)4(19)
No47(69.1)30(63.8)17(36.2)
Smoking
Yes30(46.2)22(73.3)8(26.7)
No35(53.8)23(65.7)12(34.3)
Alcohol consumption
Yes18(28.1)14(77.8)4(22.2)
No46(71.9)30(65.2)16(34.8)
Calcium supplementation
Yes5(7.4)5(100)0(0)
No63(92.6)42(66.7)21(33.3)
multivitamin supplementation
Yes27(39.7)18(66.7)9(33.3)
No41(60.3)29(70.7)12(29.3)

BMI: body mass index;

T-test or Mann-Whitney U test were used for comparison of quantitative variables and chi-square test or Fisher’s exact test were used for comparison of qualitative variables;

p value< 0.05

We categorized the amount of food groups intake (gr/day) to low and high levels according to median; then we compared the distributions of these levels of intake across the categories of Child-Pugh in Table 2 and malnutrition status in Table 3. There were significant relationship between nuts, olive and solid fat groups with Child-Pugh score (p≤0.05) (Table 2). Moreover, boiled potatoes, legumes and mayonnaise had statistically significant association with malnutrition classification (Table 3).
Table 2

Association of food groups intake (according to median) with Child-Pugh score

P value* Severity of hepatic insufficiency
Intake (g/day) Food group
Child-pugh B and C n (%) Child-pugh A n (%)
0.018[a]15(71.4)19(40.4)Low Nuts
6(28.6)28(59.6)High
0.023[a]18(85.7)27(57.4)Low Olive
3(14.3)20(42.6)High
0.030[a]7(33.3)29(61.7)Low Solid fats
14(66.7)18(38.3)High
0.79311(52.4)23(48.9)Low Vegetables
10(47.6)24(51.1)High
0.43112(57.1)22(46.8)Low Fruits
9(42.9)25(53.2)High
0.43112(57.1)22(46.8)Low Dairy
9(42.9)25(53.2)High
1.00010(47.6)24(51.1)lowGrains
11(52.4)23(48.9)high
1.00011(52.4)23(48.9)lowAnimal protein
10(47.6)24(51.1)high
0.29413(61.9)21(44.7)lowLiquid oil
8(38.1)26(55.3)high
0.6009(42.9)25(53.2)lowSweets
12(57.1) 22(46.8)high

p<0.05; Low and high is according to median; Fisher exact test or chi-square test; n (%) = Number and percent of patients

Table 3

Association of different food groups intake (according to median) with severity of malnutrition

Food groups Intake (g/day) Severity of malnutrition
P value a
SGA A n (%) SGA B n (%) SGA C n (%)
Boiled potatoLow9(33.3)23(69.7)3(37.5)0.019a
High18(66.7)10(30.3)5(62.5)
LegumeLow7(25.9)21(63.6)6(75)0.008a
High20(74.1)12(36.4)2(25)
MayonnaiseLow21(77.8)18(54.5)8(100)0.020a
High6(22.2)15(45.5)0(0)
VegetableLow10(37)18(54.5)6(75)0.137
High17(63)15(45.5)2(25)
FruitLow11(40.7)17(51.5)6(75)0.238
High16(59.3)16(48.5)2(25)
DairyLow13(48.1)16(48.5)5 (62.5)0.885
High14(51.9)17(51.5)3(37.5)
GrainsLow12(44.4)17(51.5)5(62.5)0.622
High15(55.6)16(48.5)3(37.5)
Animal proteinLow13(48.1)15(45.5)6(75)0.380
High14(51.9)18(54.5)2(25)
Liquid oilLow10(37)19(57.6)5(62.5)0.208
High17(63)14(42.4)3(37.5)
SweetsLow13(48.1)17(51.5)4(50)1.000
Table 4 shows the odd ratio (OR) and 95% confidence interval (CI) of disease severity and malnutrition for food group intakes within 2 adjusted models. In a comparison of the highest with the lowest median of food groups intake, boiled potato (model 2, OR: 0.154, CI: 0.040-0.592) and legumes intake (model 2, OR: 0.090, CI: 0.020-0.406) significantly reduced
Table 4

Odds ratio (OR) and 95% (CI) of malnutrition and severity of disease by food groups intake according to adjusted model

Child pugh-category SGA-catergory Food Group(g/day)
0.396(0.134-1.170)0.260 (0.088-0.766)*Model 1Boiled potato(12.1 vs. <12.1≤)
0.408(0.132-1.257)0.154(0.040-0.592)*Model 2
0.583(0.195-1.749)0.210(0.069-0.637)*Model 1Legume(59.25 vs. <59.25≤)
0.411(0.119-1.418)0.090(0.020-0.406)*Model 2
2.157(0.709-6.562) 3.119(1.01-11.000)*Model 1Mayonnaise(0 vs. <0≤)
2.049(0.591-7.103)5.215(1.203-22.612)*Model 2
0.190(0.054-0.666)*0.525(0.180-1.537)Model 1Nut(11.3 vs. <11.3≤)
0.140(0.031-0.625)*0.324(0.090-1.168)Model 2
0.208(0.052-0.828)*0.869(0.302-2.500)Model 1Olive(0 vs. <0≤)
0.212(0.049-0.917)*0.909(0.276-2.996)Model 2
3.324(1.080-10.238)*4.488(1.353-14.886)Model 1Solid Fat(2 vs. <2≤)
3.326(0.980-11.291)4.734(1.203-18.635)Model 2
1.030(0.314-3.82)1.189(0.372-3.799)Model 1Grains)399.3 vs.<399.3)
0.95(0.250-3.275)1.130(0.307-4.161)Model 2
0.800(0.269-2.383)1.154(0.402-3.312)Model 1Animal protein source)123.75 vs.<123.75)
0.913(0.266-3.128)0.993(0.283-3.485)Model2
0.396(0.124-1.263)0.538(0.184-1.569)Model 1Liquid oil)12.3 vs.<12.3)
0.415(0.125-1.385)0.570(0.171-1.904)Model 2
1.470(0.485-4.455)1.307(0.443-3.852)Model 1Sweets)49.75 vs.<49.75)
2.005(0.599-6.715)1.038(0.312-3.450)Model 2

p<0.05; Model 1: adjusted for energy and age; Model 2: model 1 plus BMI, smoking and alcohol consumption

risk of malnutrition, while, any consumption of mayonnaise increased malnutrition risk in both adjusted models. A decrease in disease severity was observed with increased consumption of nuts (model 2, OR:0.140, CI:0.031-0.625) and olive (model 2, OR:0.212, CI:0.049-0.917), whereas consumption of solid fats (model 1, OR:3.324, CI:1.080-10.238) was associated with increased risk of disease severity in model 1.

Discussion

In the present study, we assessed the relation between food group’s intake and severity of hepatic cirrhosis and malnutrition status. Although limited studies have shown the role of nutrition in liver disease prognosis (11-15), the role of various food groups intakes regarding disease severity and malnutrition remains open to debate. Thirteen major dietary groups were analyzed and assessed in this study. Intakes of nuts and olive inversely, and solid fats positively associated with severity of disease, while boiled potatoes and legumes consumption were associated with lower risk, and mayonnaise was associated with higher risk of malnutrition in these cirrhotic patients. Although there is no study assessing the association between food groups intake and Child-Pugh score and malnutrition status, few previous studies have reported some evidence which was in accordance with our findings. A study by Soto-alarcon et al. reported several protective effects of extra virgin olive oil on the liver, like reducing hepatic steatosis, hepatocyte ballooning, fibrogenesis and preventing lipid oxidation. In addition, extra virgin olive oil prevented inflammation, oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction and insulin resistance through inactivation of the nuclear transcription factor-κB (NF- κB) and inhibition of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathways. These effects might be due to high level of oleic acid and phenolic compounds like hydroxytyrosol and oleoropein, which have anti-oxidants properties (16). Nuts are nutritionally dense fruits, consisting of a unique blend of essential nutrients, fatty acids, and bioactive compounds. In a recent work at the Storr Liver Unit, tree nuts and walnuts in particular, improved liver function tests in patients with NAFLD through improvements of inflammation, lipid profile and hepatic steatosis (17). In our study, legumes consumption was associated with lower risk of malnutrition. Jenkins et al. suggested that higher intake of vegetable protein like legumes improve carbohydrate tolerance in cirrhotic patients. Lentil in comparison with bread and cottage cheese as breakfast decreased blood glucose and insulin due to its high content of fiber (18). Weber et al. compared the effects of a vegetable protein versus animal protein to find the components that have therapeutic effects in hepatic encephalopathy. Vegetable diet might exert beneficial effects on nitrogen balance. The key difference between animal and vegetable protein is in their amino acid profiles. Therapeutic effect of vegetable protein can be explained by reduced amount of methionine and aromatic amino acids. Moreover, high amount of fiber and complex polysaccharides, improve bacteria metabolism and increase nitrogen excretion into fecal bacteria (19). Moreover, Bianchi et al. compared the effects of mainly vegetable protein diet with an animal protein diet in cirrhotic patients and chronic permanent encephalopathy. They identified better nitrogen balance during the vegetable protein diet because of reduced urinary nitrogen excretion. In addition, plasma amino acids, ammonia, insulin, and clinical grading of encephalopathy were lower in vegetable protein diet compared with animal diet (20). Our study had some limitations including selection bias, which should also be considered in interpreting the results. In addition, we used SGA for assessment of malnutrition, which is a subjective measurement. Another problem was low number of Child-Pugh C patients, which ultimately leaves the sample inhomogeneous. This fact may jeopardize the results of the associations with the staging of the disease. Eventually, we could not directly infer causality due to the cross-sectional nature of the study design. The strengths of this study were high participation rate, using valid questionnaires and lack of residual confounding (by adjustment for important confounders). In addition, this is the first study which examined the relation between food groups intake and severity of disease and nutritional status in patients with cirrhosis. In conclusion, our findings suggested the protective effect of healthy foods such as nuts and olive on severity of hepatic cirrhosis (Child-Pugh score), and boiled potato and legumes on malnutrition status (SGA). Conversely, unhealthy food selection including solid fats and mayonnaise group were positively associated with Child-Pugh score and malnutrition respectively. Since we have a small number of patients, it is suggested to carry out new studies with prospective design to prove the present results.
  20 in total

Review 1.  Nutrition in cirrhosis and chronic liver disease.

Authors:  Wassem Juakiem; Dawn M Torres; Stephen A Harrison
Journal:  Clin Liver Dis       Date:  2013-10-25       Impact factor: 6.126

2.  Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study.

Authors:  F Manguso; G D'Ambra; A Menchise; R Sollazzo; L D'Agostino
Journal:  Clin Nutr       Date:  2005-04-07       Impact factor: 7.324

Review 3.  Nutrition in the management of cirrhosis and its neurological complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2013-06-11

4.  Nutritional status and prognosis in cirrhotic patients.

Authors:  F Gunsar; M L Raimondo; S Jones; N Terreni; C Wong; D Patch; C Sabin; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2006-07-10       Impact factor: 8.171

5.  Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open-labeled, Controlled Study.

Authors:  Zahra Yari; Mehran Rahimlou; Hossein Poustchi; Azita Hekmatdoost
Journal:  Phytother Res       Date:  2016-05-06       Impact factor: 5.878

6.  Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis.

Authors:  Luciana Carvalho; Edison Roberto Parise
Journal:  Arq Gastroenterol       Date:  2006 Oct-Dec

7.  Protein energy malnutrition predicts complications in liver cirrhosis.

Authors:  Ellen J Huisman; Evelien J Trip; Peter D Siersema; Bart van Hoek; Karel J van Erpecum
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-11       Impact factor: 2.566

Review 8.  Role of Nutrition and Muscle in Cirrhosis.

Authors:  Ragesh B Thandassery; Aldo J Montano-Loza
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

Review 9.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

10.  Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study.

Authors:  Parvin Mirmiran; Firoozeh Hosseini Esfahani; Yadollah Mehrabi; Mahdi Hedayati; Fereidoon Azizi
Journal:  Public Health Nutr       Date:  2009-10-07       Impact factor: 4.022

View more
  1 in total

Review 1.  Malnutrition in Patients with Liver Cirrhosis.

Authors:  Julia Traub; Lisa Reiss; Benard Aliwa; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.